Published in J Artif Organs on January 01, 2005
Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. Stem Cells Transl Med (2012) 0.92
Surgicel(®) (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report. Oncol Lett (2013) 0.85
Comparison of the wound healing effect of cellulose and gelatin: an in vivo study. Arch Plast Surg (2012) 0.81
A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs. Acta Pharmacol Sin (2013) 0.81
Postoperative aseptic intracranial granuloma: the possible influence of fluid hemostatics. Case Rep Surg (2012) 0.81
The long term immunological response of swine after two exposures to a salmon thrombin and fibrinogen hemostatic bandage. Biologicals (2010) 0.77
In vitro analysis of polyurethane foam as a topical hemostatic agent. J Mater Sci Mater Med (2011) 0.76
Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial. World J Surg (2015) 0.76
Efficacy evaluation of SurgiGuard® in partially hepatectomized pigs. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
Use of Gelatin Sponge Affects Postoperative Morbidity In Cesarean Section Patients. Med Sci Monit (2017) 0.75
Efficacy of Oxidized Regenerated Cellulose, SurgiGuard®, in Porcine Surgery. Yonsei Med J (2017) 0.75
A foreign body reaction to Surgicel(®) in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med (2017) 0.75
Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. Curr Ther Res Clin Exp (2011) 0.75
Comparison of the Efficiencies of Buffers Containing Ankaferd and Chitosan on Hemostasis in an Experimental Rat Model with Femoral Artery Bleeding. Turk J Haematol (2015) 0.75
Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery. J Neurol Surg B Skull Base (2016) 0.75
Next generation hemostatic materials based on NHS-ester functionalized poly(2-oxazoline)s. Biomacromolecules (2017) 0.75
Non-lethal sampling of liver tissue for toxicologic evaluation of Florida cottonmouths snakes, Agkistrodon piscivorus conanti. Ecotoxicology (2013) 0.75
[Prevention of pocket-related complications following heart rhythm device implantation. D-Stat Hemostat™ versus vacuum drainage]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Complication due to excessive use of Surgicel. Eur J Cardiothorac Surg (2001) 2.72
ABSORBABLE COTTON, PAPER AND GAUZE : (OXIDIZED CELLULOSE). Ann Surg (1943) 2.66
Imaging of retained surgical sponges in the abdomen and pelvis. AJR Am J Roentgenol (2003) 2.02
Appearance of oxidized cellulose (Surgicel) on postoperative CT scans: similarity to postoperative abscess. AJR Am J Roentgenol (1993) 1.96
A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery. Eur J Cardiothorac Surg (2002) 1.76
Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med (2004) 1.51
Immunologic response to collagen-impregnated vascular grafts: a randomized prospective study. The Canadian Multicenter Hemashield Study Group. J Vasc Surg (1990) 1.50
Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence. Br J Neurosurg (1996) 1.50
Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery. J Thorac Cardiovasc Surg (2003) 1.49
Collagen as a biomaterial. Annu Rev Biophys Bioeng (1974) 1.40
Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg (2000) 1.26
Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg (2001) 1.21
Comparative in vitro analysis of topical hemostatic agents. J Surg Res (1996) 1.18
MR characteristics of oxidized cellulose (Surgicel). AJR Am J Roentgenol (1999) 1.16
Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy--a report of three cases. Ann R Coll Surg Engl (2002) 1.08
An intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene). Arch Pathol Lab Med (1995) 1.04
Postoperative abscess mimicked by Surgicel. Abdom Imaging (1994) 1.04
Osseous reactions to three hemostatic agents. J Endod (1985) 1.00
Effects of oxidized cellulose and microfibrillar collagen on infection. Surgery (1982) 0.98
Iatrogenic paraplegia caused by surgicel used for hemostasis during a thoracotomy: report of a case. Surg Today (1997) 0.96
Antibacterial activity of oxidized regenerated cellulose. Surg Gynecol Obstet (1976) 0.96
Tissue reaction to three subcutaneously implanted local hemostatic agents. Br J Oral Maxillofac Surg (1997) 0.96
Enhancement of experimental anaerobic infections by blood, hemoglobin, and hemostatic agents. Infect Immun (1978) 0.96
Sonographic appearance of oxidized cellulose (Surgicel): pitfall in the diagnosis of postoperative abscess. J Ultrasound Med (1995) 0.95
A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed Mater Res (1986) 0.95
Paraplegia after thoracotomy--not caused by the epidural catheter. Acta Anaesthesiol Scand (1999) 0.94
Granuloma caused by oxidized cellulose following craniotomy. Acta Neurochir (Wien) (1989) 0.94
Gelfoam-induced acute quadriparesis after cervical decompression and fusion. Spine (Phila Pa 1976) (1995) 0.93
Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J Biomed Mater Res (1989) 0.92
[Intracranial foreign body granuloma caused by fine cotton fibers: a case report]. No Shinkei Geka (1994) 0.92
Injectable collagen: a six-year clinical investigation. Aesthetic Plast Surg (1985) 0.91
Lumbar cauda equina syndrome associated with the use of gelfoam: case report. Spine (Phila Pa 1976) (2001) 0.91
How safe are the xenogeneic hemostats?--Report of a case of severe systemic allergic reaction. Surg Today (1995) 0.90
Surgical management of patients on warfarin sodium. J Oral Maxillofac Surg (1996) 0.89
Collagen engineering for biomaterial use. Clin Mater (1992) 0.89
A standardized animal model for evaluation of hemostatic effectiveness of various materials. J Trauma (1983) 0.88
MRI of marked dural sac compression by surgicel in the immediately postoperative period after uncomplicated lumbar laminectomy. J Comput Assist Tomogr (1999) 0.87
Acute postoperative retroperitoneal fibrosis and ureteral obstruction secondary to the use of Avitene. Am J Obstet Gynecol (1978) 0.87
Appearance of oxidized cellulose (Surgicel) on abdominal radiographs. AJR Am J Roentgenol (1996) 0.86
Pre-clinical subdural tissue reaction and absorption study of absorbable hemostatic devices. Neurol Res (2001) 0.85
Collagen fibers as a fleece hemostatic agent. J Trauma (1980) 0.84
Bovine pericardium versus bovine collagen to buttress staples for lung reduction operations. Ann Thorac Surg (1998) 0.84
Inherent dangers of simultaneous application of microfibrillar collagen hemostat and blood-saving devices. J Thorac Cardiovasc Surg (1986) 0.83
Effect of local hemostatics on platelet aggregation. Eur Surg Res (1991) 0.83
Application of INSTAT hemostat in the control of gingival hemorrhage in the patient with thrombocytopenia. A case report. Oral Surg Oral Med Oral Pathol (1991) 0.81
Avitene granulomas of colonic serosa. Ann Clin Lab Sci (1986) 0.80
[Peculiar computed tomographic images after intracranial use of microfibrillar collagen hemostat: report of three cases]. No Shinkei Geka (1989) 0.80
The effect of oxidized regenerated cellulose on experimental intravascular infection. Surgery (1977) 0.80
Compressive optic neuropathy following use of intracranial oxidized cellulose hemostat. Ophthalmic Surg (1983) 0.80
[Coronary artery bypass graft stenosis suspected to be due to hemostatic agents: a case report]. Kyobu Geka (1991) 0.79
Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery. Ann Pharmacother (2001) 0.79
Effects of hemostatic agents on the pH of body fluids. J Endod (1986) 0.78
[A case of foreign body granuloma after aortic valve replacement]. Kyobu Geka (1990) 0.78
Removal of Avitene microfibrillar collagen hemostat by use of suitable transfusion filters. Ann Thorac Surg (1994) 0.77
Cost/benefit analysis of pharmacologic hemostasis. Ann Thorac Surg (1996) 0.77
In vitro effect of a microfibrillar collagen hemostat on platelets. Haemostasis (1987) 0.77
Histologic and immunohistochemical features in biopsy sites in which bovine collagen matrix was used for hemostasis. J Am Acad Dermatol (1996) 0.76
Effect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging. J Neurosurg (2001) 0.75
[Evaluation of blood absorption, hemostatic ability and purity of a polyepoxy compound cross-linked cotton type collagen hemostat]. Kyobu Geka (1996) 0.75
Histologic study of use of microfibrillar collagen hemostat in rat dental sockets. Braz Dent J (2003) 0.75
Effective management of bleeding during tumor resection with a collagen-based hemostatic agent. Am Surg (2002) 0.75
Hemostatic agent and concomitant abdominal abscess. AJR Am J Roentgenol (1994) 0.75